Literature DB >> 8889343

Blinding during data analysis and writing of manuscripts.

P C Gøtzsche1.   

Abstract

Mesh：

Year:  1996        PMID： 8889343     DOI： 10.1016/0197-2456(95)00263-4

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN： 0197-2456


× No keyword cloud information.
  32 in total

1.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

2.  Believability of relative risks and odds ratios in abstracts: cross sectional study.

Authors:  Peter C Gøtzsche
Journal:  BMJ       Date:  2006-07-19

3.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

Review 4.  Towards a proposal for assessment of blinding success in clinical trials: up-to-date review.

Authors:  Jafar Kolahi; Heejung Bang; Jongbae Park
Journal:  Community Dent Oral Epidemiol       Date:  2009-09-15       Impact factor: 3.383

5.  A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression.

Authors:  Ulla Knorr; Maj Vinberg; Anders Gade; Per Winkel; Christian Gluud; Jørn Wetterslev; Ulrik Gether; Lars Kessing
Journal:  Ther Adv Psychopharmacol       Date:  2011-10

6.  Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trial.

Authors:  Ulla Knorr; Maj Vinberg; Allan Hansen; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Jørgen Hasselstrøm; Ulrik Gether; Per Winkel; Christian Gluud; Jørn Wetterslev; Lars Vedel Kessing
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

7.  Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol.

Authors:  Lone Baandrup; Birgitte Fagerlund; Poul Jennum; Henrik Lublin; Jane L Hansen; Per Winkel; Christian Gluud; Bob Oranje; Birte Y Glenthoj
Journal:  BMC Psychiatry       Date:  2011-10-05       Impact factor: 3.630

8.  Perioperative oxygen fraction - effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial.

Authors:  Christian S Meyhoff; Jørn Wetterslev; Lars N Jorgensen; Steen W Henneberg; Inger Simonsen; Therese Pulawska; Line R Walker; Nina Skovgaard; Kim Heltø; Peter Gocht-Jensen; Palle S Carlsson; Henrik Rask; Sharaf Karim; Charlotte G Carlsen; Frank S Jensen; Lars S Rasmussen
Journal:  Trials       Date:  2008-10-22       Impact factor: 2.279

Review 9.  Challenges in coding adverse events in clinical trials: a systematic review.

Authors:  Jeppe Bennekou Schroll; Emma Maund; Peter C Gøtzsche
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

10.  Interval exercise versus continuous exercise in patients with moderate to severe chronic obstructive pulmonary disease--study protocol for a randomised controlled trial [ISRCTN11611768].

Authors:  Milo A Puhan; Gilbert Büsching; Evelien VanOort; Christian Zaugg; Holger J Schünemann; Martin Frey
Journal:  BMC Pulm Med       Date:  2004-08-13       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.